These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20690108)

  • 61. Group sequential procedures for repeated events data with frailty.
    Jiang W
    J Biopharm Stat; 1999 Aug; 9(3):379-99. PubMed ID: 10473027
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Power comparisons for group sequential tests with nonparametric statistics in case of nonproportional hazards.
    Demirhan H; Demirhan YP; Bacanli S
    J Biopharm Stat; 2013 Mar; 23(2):447-60. PubMed ID: 23437950
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance.
    Li H; Wang J; Luo X; Grechko J; Jennison C
    Biom J; 2018 Sep; 60(5):893-902. PubMed ID: 29876964
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exact critical values for group sequential designs with small sample sizes.
    Rom DM; McTague JA
    J Biopharm Stat; 2020 Jul; 30(4):752-764. PubMed ID: 32151177
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CP function: an alpha spending function based on conditional power.
    Jiang Z; Wang L; Li C; Xia J; Wang W
    Stat Med; 2014 Nov; 33(26):4501-14. PubMed ID: 25100033
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Violations of the independent increment assumption when using generalized estimating equation in longitudinal group sequential trials.
    Shoben AB; Emerson SS
    Stat Med; 2014 Dec; 33(29):5041-56. PubMed ID: 25224560
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sequential analysis of longitudinal data in a prospective nested case-control study.
    Park E; Chang YC
    Biometrics; 2010 Dec; 66(4):1034-42. PubMed ID: 20002402
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Flexible designs by adaptive plans of generalized Pocock- and O'Brien-Fleming-type and by self-designing clinical trials.
    Hartung J
    Biom J; 2006 Aug; 48(4):521-36. PubMed ID: 16972703
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Determination of power and sample size in the design of clinical trials with failure-time endpoints and interim analyses.
    Gu M; Lai TL
    Control Clin Trials; 1999 Oct; 20(5):423-38. PubMed ID: 10503802
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Group sequential designs with robust semiparametric recurrent event models.
    Mütze T; Glimm E; Schmidli H; Friede T
    Stat Methods Med Res; 2019 Aug; 28(8):2385-2403. PubMed ID: 29890892
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interim monitoring of sequential multiple assignment randomized trials using partial information.
    Manschot C; Laber E; Davidian M
    Biometrics; 2023 Dec; 79(4):2881-2894. PubMed ID: 36896962
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Exact and Monte carlo resampling procedures for the Wilcoxon-Mann-Whitney and Kruskal-Wallis tests.
    Berry KJ; Mielke PW
    Percept Mot Skills; 2000 Dec; 91(3 Pt 1):749-54. PubMed ID: 11153842
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Group sequential monitoring based on the weighted log-rank test statistic with the Fleming-Harrington class of weights in cancer vaccine studies.
    Hasegawa T
    Pharm Stat; 2016 Sep; 15(5):412-9. PubMed ID: 27353855
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Conditional Monte Carlo randomization tests for regression models.
    Parhat P; Rosenberger WF; Diao G
    Stat Med; 2014 Aug; 33(18):3078-88. PubMed ID: 24648378
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The use of generalized tests in medical research.
    Ogenstad S
    J Biopharm Stat; 1998 Nov; 8(4):497-508. PubMed ID: 9855030
    [No Abstract]   [Full Text] [Related]  

  • 76. Monitoring multi-armed trials.
    Proschan MA; Follmann DA; Geller NL
    Stat Med; 1994 Jul 15-30; 13(13-14):1441-52. PubMed ID: 7973223
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Testing a primary and a secondary endpoint in a group sequential design.
    Tamhane AC; Mehta CR; Liu L
    Biometrics; 2010 Dec; 66(4):1174-84. PubMed ID: 20337631
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A U-statistics based approach to sample size planning of two-arm trials with discrete outcome criterion aiming to establish either superiority or noninferiority.
    Wellek S
    Stat Med; 2017 Feb; 36(5):799-812. PubMed ID: 27878839
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Estimation of hurst exponent for sequential monitoring of clinical trials with covariate adaptive randomization.
    Yang Y; Zhu H; Lai D
    Contemp Clin Trials; 2022 Sep; 120():106887. PubMed ID: 35988662
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sample size calculation for planning group sequential longitudinal trials.
    Liu A; Boyett JM; Xiong X
    Stat Med; 2000 Jan; 19(2):205-20. PubMed ID: 10641025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.